HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
AIM Increased basal cortisol secretion has been associated with heightened clinical risk for psychosis, and among at-risk individuals, has been variably related to positive and mood symptoms, as well as clinical outcome. METHODS Basal salivary cortisol secretion was assessed in 33 patients at clinical high risk (CHR) for psychosis (21 medication-free and 12 taking a serotonin reuptake inhibitor and/or atypical antipsychotic), and 13 healthy controls. Among the CHR patients, we also examined associations of basal salivary cortisol with symptoms (positive, negative, mood, stress sensitivity) and clinical outcome. RESULTS Basal salivary cortisol secretion was significantly higher in CHR patients who were medication-free compared to CHR patients taking medications and to healthy controls. In this small cohort, basal salivary cortisol secretion was associated at trend level with stress sensitivity, and was not significantly related to other symptoms. CONCLUSIONS Our finding of elevated basal cortisol secretion in CHR patients supports the premise that excess activation of the HPA axis and/or neuroendocrine abnormalities characterize the psychosis risk state for at least a subset of patients. Our findings further suggest that psychotropic medications may have a normalizing effect on HPA-axis dysfunction in CHR patients, which could potentially inform intervention strategies for the prodrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex differences in HPA axis responses to stress: a review
Kudielka, B. M., & Kirschbaum, C. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2004.11.009 · Cited by 1,624
Schizophrenia: A neural diathesis-stress model.
Walker, E. F., & Diforio, D. (1997) · Psychological Review · doi:10.1037//0033-295x.104.4.667 · Cited by 930
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615 · cited 1×
“Antidepressant and antipsychotic medications have been reported to dampen HPA-axis activity through effects on central nervous system glucocorticoid receptors (Walker et al., 2008; Pariante et al., 2012).”
BackgroundThe stress cascade and schizophrenia: Etiology and onset
Corcoran, C., Walker, E., Huot, R., Mittal, V., Tessner, K., Kestler, L., & Malaspina, D. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007038 · Cited by 439 · cited 2×
“…et al., 2004), it has been proposed that stress contributes to the development of psychosis through effects of the hypothalamic pituitary adrenal (HPA) axis, and interaction of cortisol with dopaminergic neurotransmission and hippocampal circuitry (Corcoran et al., 2003; Thompson et al., 2004).”
BackgroundSelf-citationMondelli, V., Dazzan, P., Hepgul, N., Di Forti, M., Aas, M., D'Albenzio, A., Di Nicola, M., Fisher, H., Handley, R., Marques, T. R., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.08.013 · Cited by 278 · cited 2×
“Both antipsychotic (Mondelli et al., 2010; Zhang et al., 2005; Scheepers et al., 2001) and antidepressant (Pariante et al.”
BackgroundIncreased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Ryan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225 · cited 2×
“HPA-axis abnormalities, specifically elevated cortisol levels, have been observed in first-episode drugnaïve patients with schizophrenia (Ryan et al., 2004), in the siblings of patients with a psychotic disorder (Collip et al.”
BackgroundDo antidepressants regulate how cortisol affects the brain?
Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.009 · Cited by 194
Developmental changes in cortisol secretion in normal and at-risk youth
WALKER, E. F., WALDER, D. J., & REYNOLDS, F. (2001) · Development and Psychopathology · doi:10.1017/s0954579401003169 · Cited by 183
Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.
Walker, E. F., Brennan, P. A., Esterberg, M., Brasfield, J., Pearce, B., & Compton, M. T. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0018399 · Cited by 127 · cited 5×
“In exploratory analysis, we observed non-significantly lower baseline cortisol levels in patients who later transitioned to psychosis, in contrast to the findings of Walker et al. (2010).”
BackgroundResultInfluentialHypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis
Belvederi Murri, M., Pariante, C. M., Dazzan, P., Hepgul, N., Papadopoulos, A. S., Zunszain, P., Di Forti, M., Murray, R. M., & Mondelli, V. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.013 · Cited by 93 · cited 1×
“Cortisol secretion has also been associated with positive symptoms in patients with psychotic disorder (Belvederi Murri et al., 2012), in their siblings (Collip et al., 2011), and in individuals at increased clinical risk (Walker et al., 2001; Corcoran et al., 2012), while mood symptoms have been…”
BackgroundHPA axis function and symptoms in adolescents at clinical high risk for schizophrenia
Corcoran, C. M., Smith, C., McLaughlin, D., Auther, A., Malaspina, D., & Cornblatt, B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.035 · Cited by 85 · cited 12×
“…(Belvederi Murri et al., 2012), in their siblings (Collip et al., 2011), and in individuals at increased clinical risk (Walker et al., 2001; Corcoran et al., 2012), while mood symptoms have been variably associated with cortisol levels in CHR cohorts (Thompson et al., 2007; Corcoran et al., 2012).”
BackgroundMethodResultInfluentialSelf-citationPituitary volume, stress reactivity and genetic risk for psychotic disorder
Habets, P., Collip, D., Myin-Germeys, I., Gronenschild, E., van Bronswijk, S., Hofman, P., Lataster, T., Lardinois, M., Nicolson, N. A., van Os, J., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711002728 · Cited by 46
Walder, D. J., Statucka, M., Daly, M. P., Axen, K., & Haber, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.09.009 · Cited by 40 · cited 4×
“, 2001) and gender differences (Walder et al., 2012) in cortisol secretion, age and gender were included as covariates in statistical analyses.”
BackgroundMethodResultInfluentialPariante, C. M., Alhaj, H. A., Arulnathan, V. E., Gallagher, P., Hanson, A., Massey, E., & McAllister-Williams, R. H. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.011 · Cited by 33 · cited 2×
“Psychotropic medications are known to influence HPA-axis function (e.g., Pariante et al., 2012).”
Background
Cited by
Pruessner, M., Cullen, A. E., Aas, M., & Walker, E. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.013 · Cited by 315
The interface of stress and the HPA axis in behavioural phenotypes of mental illness
Baumeister, D., Lightman, S. L., & Pariante, C. M. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_304 · Cited by 104
“Clinical high risk for psychosis in medication-free individuals is also associated with elevated basal salivary cortisol (Sugranyes et al. 2012).”
BackgroundCullen, A. E., Zunszain, P. A., Dickson, H., Roberts, R. E., Fisher, H. L., Pariante, C. M., & Laurens, K. R. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.010 · Cited by 75
“, 2011), youth at UHR (Sugranyes et al., 2012; Walker et al., 2013) and adolescents with SPD (Walker et al.”
BackgroundResultInfluentialCarol, E. E., & Mittal, V. A. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.03.018 · Cited by 44
Coulon, N., Brailly-Tabard, S., Walter, M., & Tordjman, S. (2016) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2017.05.002 · Cited by 28
Metadata
- Authors
- Sugranyes, G., Thompson, J. L., & Corcoran, C. M.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 46
- Issue
- 11
- Pages
- 1389-1393
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2080980787
- Cited by
- 45
- References
- 15
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.